Do you want to read an article? Please log in or register.
Diffuse lung diseases ascribed to drugs: a nationwide observational study over 37 years using the French pharmacovigilance database
Interstitial Lung Disease
RECOMMENDED
Related content
RECOMMENDED
Asthma
A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Sci Rep
Song Y, Wang Z, Wang N, Xie X, Zhu T, Wang Y
doi: 10.1038/s41598-025-91463-5
RECOMMENDED
Interstitial Lung DiseasePneumonia
Clinical Profiles, Survival, and Lung Function Outcomes in ANCA-Associated Interstitial Lung Disease: An Observational Study
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Valero-Martínez C, Valenzuela C, Baldivieso Achá JP, Martínez-Besteiro E, Quiroga-Colina P, Alfranca A, Vicente-Rabaneda EF, Muñiz SH, Castañeda S, García-Vicuña R
doi: 10.3390/jcm14010229
Pulmonary Fibrosis
LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis
J Cyst Fibros
Vega-Hernandez G, MacGregor G, Wilfin A, Adams F, Haugh C, Baxter CA, Wöhling H, Clarke SL, Charman SC, Carr SB
doi: 10.1016/j.jcf.2025.04.012
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Association Between Calcium Channel Blocker Use and the Risk of Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: A Longitudinal Cohort Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Jang HJ, Seong YM, Jeong J, Huh JY, Kim JH, Kim KH, Park JH, Choi WI
doi: 10.1016/j.rmed.2025.107939
RECOMMENDED
COPD
Tracking Real-World Physical Activity in Chronic Obstructive Pulmonary Disease Over One Year: Results from a Monocentric, Prospective, Observational Cohort Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Int J Chron Obstruct Pulmon Dis
Boesch M, Baty F, Bilz S, Brutsche MH, Rassouli F
doi: 10.2147/COPD.S469984
Tuberculosis
Risk of tuberculosis disease among patients with inflammatory bowel disease and inflammatory rheumatic disease treated with biologics in Denmark: a nationwide cohort study
Clin Microbiol Infect
Kraef C, Østergaard AA, Lillebaek T, Ravn P, Fløe A, Larsen L, Colic A, Petersen I, Johansen IS
doi: 10.1016/j.cmi.2025.06.017
Interstitial Lung Disease
Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysis
Semin Arthritis Rheum
Zhang Q, McDermott GC, Juge PA, Chang SH, Vanni KM, Qian G, Bade KJ, Mueller KT, Kowalski EN, Saavedra AA, Sparks JA
doi: 10.1016/j.semarthrit.2024.152561
COMMENTED
Interstitial Lung DiseaseFurther Publications
Performance of Lung Ultrasound as a Screening Tool for Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: a Multicenter Study
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Maria O, Eirini V, Sébastien O, Marwin G, Soledad DM, Adrian G, Pierre-Antoine J, Chiara B, Nestor A, Christos S, Maricel DM, Paola O, Alan QR, Marie-Pierre D, Barbara PC, Emilce S, Prodromos S, Nicolas LS, Marcos R, Sebastian M, Katerina A
doi: 10.1016/j.chest.2024.11.038
RECOMMENDED
Pulmonary Fibrosis
The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Burgel PR, Sermet-Gaudelus I, Girodon E, Durieu I, Houdouin V, Audousset C, Macey J, Grenet D, Porzio M, Murris-Espin M, Reix P, Baravalle M, Belleguic C, Mely L, Verhille J, Weiss L, Reynaud-Gaubert M, Mittaine M, Hamidfar R, Ramel S, Cosson L, Douvry B, Danner-Boucher I, Foucaud P, Roy C, Burnet E, Raynal C, Audrezet MP, Da Silva J, Martin C, French Cystic Fibrosis Reference Network study group
doi: 10.1016/S2213-2600(24)00208-X